Macquarie Group
BDSI

Macquarie Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Macquarie Group’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,200
Closed -$33K – 2565
2017
Q4 		$33K Buy
+11,200
New +$31K ﹤0.01% 2094

Other funds holding BDSI

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Macquarie Group's BDSI Position: Q1 2018 in Review

Macquarie Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2018, closing a stake of 11,200 shares — an estimated $33K sold.

Macquarie Group first reported a position in BDSI in Q4 2017 and held it in 1 quarter. The position peaked at $33K in Q4 2017. 68 funds tracked by Wall St. Rank hold BDSI as of Q1 2018.

  • Macquarie Group reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2018 after selling out during the quarter.
  • Macquarie Group sold 11,200 BioDelivery Sciences International, Inc. shares in Q1 2018, an estimated $33K.
  • Macquarie Group first reported a position in BioDelivery Sciences International, Inc. in Q4 2017 and held it in 1 quarter.
  • Macquarie Group's BioDelivery Sciences International, Inc. position peaked at $33K in Q4 2017.
  • 68 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.